August Bioservices

company

About

August Bioservices is an expert, collaborative, drug discovery, clinical development, and clinical manufacturing company.

Details

Last Funding Type
Series B
Last Funding Money Raised
$65M
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2017
Number Of Employee
101 - 250
Operating Status
Active
Also Known As
PMI BioPharma Solutions

August Bioservices is a contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing services. August Bioservices provides comprehensive service offering to advance drug discovery, pharmaceutical development, and clinical manufacturing for the pharmaceutical and biotechnology industries. PMI BioPharma Solutions is uniquely positioned to support individual projects or to serve as an extension of its customers’ development teams. PMI BioPharma Solutions is planning to scale its manufacturing capabilities to support late-stage clinical and commercial liquid and lyophilized filling demand, to help support projects from clinical development to commercial launch.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$88.60M
August Bioservices has raised a total of $88.60M in funding over 2 rounds. Their latest funding was raised on Dec 1, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 1, 2022 Series B $65M 2 Oak HC/FT Detail
May 27, 2021 Series A $23.60M 2 Polaris Partners Detail
Jul 16, 2020 Series Unknown 1 Oak HC/FT Detail

Investors

Number of Lead Investors
Number of Investors
3
2
August Bioservices is funded by 2 investors. Oak HC/FT and Polaris Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Oak HC/FT Yes Series B
Polaris Partners Series B

Employee Profiles

Number of Employee Profiles
3
August Bioservices has 3 current employee profiles, including Board member Brian Chee
Board member
Executive
Executive